Cargando…
Tissue-selective therapy of cancer
Instead of exploiting the differences between normal and cancer cells, seemingly unrelated anticancer modalities (from immunotherapy to hormones) exploit (a) the differences between various normal tissues and (b) tissue-specific similarities of normal and cancer cells. Although these therapies are s...
Autor principal: | Blagosklonny, M V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394286/ https://www.ncbi.nlm.nih.gov/pubmed/14520435 http://dx.doi.org/10.1038/sj.bjc.6601256 |
Ejemplares similares
-
Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
por: Silk, Tarik, et al.
Publicado: (2022) -
Marine polyunsaturated fatty acids and cancer therapy
por: Vaughan, V C, et al.
Publicado: (2013) -
Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development
por: Hojilla, C V, et al.
Publicado: (2003) -
Prevalence and implications of elevated microsatellite alterations at selected tetranucleotides in cancer
por: Watson, M M C, et al.
Publicado: (2014) -
Stem cells from adipose tissue and breast cancer: hype, risks and hope
por: Bertolini, F, et al.
Publicado: (2015)